Rastegar H

References (3)

Title : Phenyl-quinoline derivatives as a lead structure of cholinesterase inhibitor endowed with potency to reduce the GSK-3beta level targeting Alzheimer's disease - Noori_2023_Int.J.Biol.Macromol__127392
Author(s) : Noori M , Dastyafteh N , Safapoor S , Ghomi MK , Tanideh R , Zomorian K , Hamedifar H , Dara M , Zare S , Irajie C , Javanshir S , Rastegar H , Panahi N , Larijani B , Mahdavi M , Hajimiri MH , Iraji A
Ref : Int J Biol Macromol , :127392 , 2023
Abstract : Noori_2023_Int.J.Biol.Macromol__127392
ESTHER : Noori_2023_Int.J.Biol.Macromol__127392
PubMedSearch : Noori_2023_Int.J.Biol.Macromol__127392
PubMedID: 37827412

Title : Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives - Pedrood_2021_Int.J.Biol.Macromol_170_1
Author(s) : Pedrood K , Sherafati M , Mohammadi-Khanaposhtani M , Asgari MS , Hosseini S , Rastegar H , Larijani B , Mahdavi M , Taslimi P , Erden Y , Gunay S , Gulcin I
Ref : Int J Biol Macromol , 170 :1 , 2021
Abstract : Pedrood_2021_Int.J.Biol.Macromol_170_1
ESTHER : Pedrood_2021_Int.J.Biol.Macromol_170_1
PubMedSearch : Pedrood_2021_Int.J.Biol.Macromol_170_1
PubMedID: 33352155

Title : New quinoxalin-1,3,4-oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies - Mirzazadeh_2021_Arch.Pharm.(Weinheim)__e2000471
Author(s) : Mirzazadeh R , Asgari MS , Barzegari E , Pedrood K , Mohammadi-Khanaposhtani M , Sherafati M , Larijani B , Rastegar H , Rahmani H , Mahdavi M , Taslimi P , Uc EM , Gulcin I
Ref : Arch Pharm (Weinheim) , :e2000471 , 2021
Abstract : Mirzazadeh_2021_Arch.Pharm.(Weinheim)__e2000471
ESTHER : Mirzazadeh_2021_Arch.Pharm.(Weinheim)__e2000471
PubMedSearch : Mirzazadeh_2021_Arch.Pharm.(Weinheim)__e2000471
PubMedID: 33999440